Monday, August 12, 2013 10:45:13 AM
It seems the stance the market took with mEnox and is now taking with mCopax is that there are just too many variables, any one of which could torpedo the stock price, and as a result the present value of the stock is valued extremely conservatively.
Do you disagree with this? How else can you explain the mEnox scenario as it played out and even recent events with mCopax? Does it make sense to you that the gains related to the court case victory would have disappeared this quickly were this not true?
MNTA is less than 1 year away from possibly selling their generic of a multi-billion dollar drug (perhaps alone) and the market seems to discount its current valuation heavily. I can only assume this is due to heavy skepticism that it will play out as many here assume it will.
MNTA's stock price never made sense to me with mEnox but after witnessing how it played out it makes all the sense in the world to me today.
FEATURED Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
